Array Biopharma To Present At The Bank Of America Merrill Lynch 2018 Health Care Conference

PR Newswire

BOULDER, Colo., May 9, 2018

BOULDER, Colo., May 9, 2018 /PRNewswire/ -- Array BioPharma Inc. ARRY today announced that its Chief Executive Officer, Ron Squarer, will speak at the Bank of America Merrill Lynch 2018 Health Care Conference in Las Vegas. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.

Event:	Bank of America Merrill Lynch 2018 Health Care Conference
Presenter:	Ron Squarer, Chief Executive Officer, Array BioPharma
Date:	Wednesday, May 16, 2018
Time:	8:40 a.m. Pacific Time
Webcast:	http://www.veracast.com/webcasts/baml/healthcare2018/id01202184563.cfm

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other conditions. Ten registration studies are currently advancing related to eight Array-owned or partnered drugs: encorafenib (LGX818), binimetinib (MEK162), ARRY-797, selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Seattle Genetics). For more information on Array, please go to www.arraybiopharma.com.

CONTACT:
Andrea N. Flynn, Ph.D.
Senior Director, Investor Relations & Corporate Communications
(303) 381-6600
ir@arraybiopharma.com

Array BioPharma. (PRNewsFoto/Array BioPharma Inc.) (PRNewsFoto/)

View original content with multimedia:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-bank-of-america-merrill-lynch-2018-health-care-conference-300645764.html

SOURCE Array BioPharma

Market News and Data brought to you by Benzinga APIs